Horse Chestnut (Aescin) in Cardioflush: Dose vs. Trial Evidence for Circulation Support

What Cardioflush's label actually says about horse chestnut

Cardioflush is sold as "CARDIOFLUSH — CARDIO SUPPORT DROPS," a liquid dietary supplement distributed by MJO of Sheridan, Wyoming, in an amber glass bottle with a dropper. The printed Supplement Facts panel gives a serving size of 2ml (two droppers), with 30 servings in each 60mL (2 fl oz) bottle. Underneath that serving size sits a single line: "Proprietary Blend — 195mg," followed by the six botanicals it contains, listed in this printed order: Grape Seed (Vitis vinifera) Extract [>95% Proanthocyanidins], Horse Chestnut (Aesculus hippocastanum) Extract [>20% Aescin], Motherwort (Leonurus japonicus whole herb) Extract, Hawthorn Berry (Crataegus asiatica aerial) Extract, Gotu Kola (Centella asiatica aerial) Extract, and Butcher's Broom (Ruscus aculeatus leaf/stem) Extract.

Two of those six ingredients carry a printed standardization: Grape Seed at greater than 95% proanthocyanidins, and Horse Chestnut at greater than 20% aescin. That second figure, ">20% Aescin," tells you the concentration of the active-compound fraction within the horse chestnut extract itself — it does not tell you how many milligrams of that extract are actually in the bottle. A concentration percentage and an absolute dose are two different pieces of information, and the label only discloses the first one. Under U.S. supplement labeling rules, a "proprietary blend" is allowed to disclose only the combined weight of its ingredients, not the individual amounts, as long as the ingredients are listed in descending order by weight — which is exactly the format used here. Horse chestnut's position second on the list suggests it is present in a larger amount than the four ingredients listed after it, but that is an ordering rule, not a milligram figure.

What horse chestnut extract and aescin actually are

Horse chestnut (Aesculus hippocastanum) is a large flowering tree native to the Balkans, long used in European herbal medicine for leg swelling and varicose-vein symptoms. The seed contains a mixture of triterpene saponins collectively called aescin (also spelled escin), which is considered the extract's primary active fraction. Aescin is thought to work by tightening the walls of veins and capillaries and reducing the leakiness that lets fluid seep into surrounding tissue — the process behind the heavy, swollen feeling associated with chronic venous insufficiency. This is a distinct mechanism from Cardioflush's other five ingredients, and it is the reason horse chestnut extract, specifically standardized for aescin content, has its own clinical-trial literature separate from the other botanicals on the label.

It's worth being precise about a safety distinction here too: raw, unprocessed horse chestnut seed also contains a compound called esculin, which is toxic and must be removed during processing. Every study discussed below used a standardized, processed pharmaceutical-grade extract, not raw seed — the same category of ingredient the Cardioflush label describes with its ">20% Aescin" standardization.

What the clinical trials actually used and found

The most authoritative summary of horse chestnut seed extract research is a Cochrane systematic review, most recently updated in 2012, which pooled 17 randomized, placebo-controlled or comparator trials in people with chronic venous insufficiency.^[1] An earlier, separate criteria-based systematic review by the same lead author, published in 1998, reached a similar conclusion using a smaller set of trials.^[2] Across the trials the Cochrane review examined, the standardized extract most commonly used delivered roughly 50mg of aescin per dose, taken twice daily — about 100mg of aescin across a full day. That aescin amount was typically packaged as roughly 300mg of horse chestnut seed extract standardized to somewhere in the 16–21% aescin range, taken twice daily, which lines up with the general strength range that Cardioflush's own ">20% Aescin" standardization sits within.

Using that dosing pattern, the Cochrane review reported that horse chestnut seed extract reduced leg pain, and modestly reduced leg volume and edema (fluid swelling), compared with placebo. Several of the included trials also compared horse chestnut extract against a reference treatment, external compression stockings, and reported broadly comparable symptom improvement between the two approaches over several weeks. The review authors were careful to flag that a number of the included trials had shortcomings in their methodology and were not large by modern standards, and they explicitly called for larger, better-designed studies rather than treating the evidence as settled. That is a meaningfully positive signal for standardized horse chestnut extract as a category — but it is a signal tied to a specific, disclosed daily aescin amount, not to horse chestnut in general at any amount.

Trial dose vs. what Cardioflush discloses

	Amount	Disclosed on label?
Aescin used per day in the pooled Cochrane trials	~100mg (commonly ~50mg twice daily)	—
Horse chestnut extract typically providing that aescin amount	~300mg twice daily, standardized to 16–21% aescin	—
Cardioflush's entire six-ingredient proprietary blend	195mg total, per 2ml serving	Yes, as a blend total
Cardioflush's horse chestnut extract specifically	Not stated	No — only the >20% aescin standardization is printed, not a milligram amount

The arithmetic is worth sitting with. The trial doses that produced the Cochrane review's findings totaled roughly 600mg of standardized extract a day, on its own. Cardioflush's entire proprietary blend — horse chestnut plus five other botanicals combined — totals 195mg for the whole day's serving. That does not prove the horse chestnut portion is too low to matter; a highly concentrated extract can deliver meaningful aescin in a smaller weight of material, and extract-to-extract potency varies. But it does mean there is no published number on this label that lets a buyer calculate how the horse chestnut in this bottle compares with the horse chestnut used in the trials. That gap is the honest answer to "does Cardioflush contain a clinical dose of horse chestnut" — nobody outside the manufacturer currently has the information to answer it.

Safety and interaction notes

In the trials reviewed by Cochrane, standardized horse chestnut seed extract was generally well tolerated, with the most commonly reported side effects being mild gastrointestinal upset, dizziness, headache, nausea or itching. Rates of these effects were generally similar to placebo across most trials. That safety profile applies to the standardized, aescin-quantified extract used in research — it is not a safety statement about Cardioflush as a finished six-botanical liquid blend, which has not itself been through a clinical trial.

Cardioflush's own label carries a general caution: "Check with your doctor before using this product if you are using medication or have any medical conditions." That is a reasonable instruction to take seriously rather than skip past, particularly because several of the other five botanicals in the same blend — discussed in our companion articles on reading Cardioflush's proprietary blend label and on gotu kola and butcher's broom evidence — also touch circulation and clotting pathways. Horse chestnut extract in particular has a theoretical interaction with anticoagulant and antiplatelet medications given its effect on vein and vessel walls; anyone taking blood thinners should raise this specific ingredient with a pharmacist or physician before starting a horse-chestnut-containing product, rather than relying on the label's general caution alone.

Where the evidence stops

Two limits are worth stating plainly, because they apply specifically to horse chestnut and not just to the blend as a whole. First, no clinical trial has tested Cardioflush itself, or any product combining horse chestnut with grape seed, motherwort, hawthorn, gotu kola and butcher's broom in a single 195mg blend — the research discussed above is on horse chestnut extract alone, dosed on its own. Second, and specific to this label: a proprietary blend format legally permits withholding individual ingredient amounts, and Cardioflush's manufacturer has exercised that option for all six ingredients. That is common industry practice, not unique to this product, but it means the single most useful number for judging whether this bottle matches the horse chestnut research — the milligrams of horse chestnut extract per serving — is simply not published anywhere we could find, including on the Amazon listing where this product is sold.

Related reading

• What "proprietary blend" means: how to read the Cardioflush label
• Gotu kola and butcher's broom for venous circulation: what the research shows
• Heart supplement drops vs. capsules: what the dose form changes
• Heart supplement and drug interactions: a safety guide

Frequently asked questions